News Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:46 10/03/2026 pm IST			5-day change	1st Jan Change
353.60 ^INR	+1.38%		-1.10%	-14.14%

07/03	Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited	CI
04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026

All News

07/03	Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited	CI
09/02	For interim dividend	FA
04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Aarti Drugs dividend 2 rupees per share	RE
03/02	Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
03/02	Aarti Drugs Dec-quarter Consol Net Profit 405.4 Million Rupees	RE
03/02	Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2025-26	CI
10/11	Aarti Drugs Limited, Q2 2026 Earnings Call, Nov 10, 2025
08/11	Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
05/25/05	Aarti Drugs Sayakha Plant Commences Commercial Production	MT
04/25/04	Aarti Drugs commences commercialization of manufacturing plant located at Sayakha	RE
21/25/21	Aarti Drugs Limited, Q1 2026 Earnings Call, Jul 21, 2025
18/25/18	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
07/25/07	Aarti Drugs Limited, Q4 2025 Earnings Call, May 07, 2025
07/25/07	Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	MT
06/25/06	Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
06/25/06	Aarti Drugs March-Quarter Consol Net Profit 628.6 Mln Rupees	RE
07/25/07	Aarti Drugs Receives Administrative Warning Letter From SEBI	RE
06/25/06	Aarti Drugs Says SEBI Issues Administrative Warning To Co's Compliance Officer, Company Secretary	RE
06/25/06	Pro-Zeal Green Power Nine Private Limited announced that it has received INR 80.52 million in funding from Aarti Drugs Limited	CI
14/25/14	US FDA Removes Import Alert on Aarti Drugs Limited's API Manufacturing Facility	CI
07/25/07	Aarti Drugs Limited Receives an Order Refer with GST DRC-07 from the CGST & C.Ex. Authority	CI
04/25/04	For interim dividend	FA
03/25/03	Aarti Drugs To Acquire 26.25% Equity In Pro-ZEAL Green Power Nine	RE
30/25/30	Aarti Drugs' Consolidated Net Profit Rises in Fiscal Q3	MT